EIF3B and non-small cell lung carcinoma: Moreover, METTL3 induces non-small cell lung cancer (NSCLC) drug resistance and metastasis by promoting Yes-associated protein (YAP) mRNA translation via a m6A -YTHDF1/3/eIF3b-dependent mechanism (Jin D. et al., 2019).